GlassScriptPhysician profile
Mazin Khalid
NPI 1083020812
$9,470.10
in general payments reported to CMS, 2019-2025
25 companies · $767 in 2025
The $767 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.98 · 2020: $351 · 2021: $800 · 2022: $4,415 · 2023: $2,623 · 2024: $483 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,747 · Grant: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,746.86 |
| Grant | $1,126.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,597.96 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $1,397.95 | 2021-2025 | Cds - Mct/Cem Monitoring |
| Astrazeneca Pharmaceuticals LP | $1,044.69 | 2020-2023 | Brilinta |
| Abiomed | $401.37 | 2023 | Impella |
| Amgen INC. | $371.15 | 2021-2025 | Repatha |
| Cvrx, INC. | $346.91 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $202.63 | 2023-2025 | Diamondback Peripheral, Pressurewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $188.25 | 2024-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $116.46 | 2020-2023 | Camzyos |
| Shockwave Medical, INC | $104.91 | 2022 | |
| Astellas Pharma US INC | $99.99 | 2021 | |
| Cardiva Medical, INC. | $99.64 | 2023-2025 | Optowire, Cardiva Vascade 6/7f Vcs |
| Cordis US Corp. | $98.07 | 2025 | Mynx Control Venous |
| Edwards Lifesciences Corporation | $92.89 | 2024 | Sapien 3 Ultra Resilia |
| Terumo Medical Corporation | $75.69 | 2020-2025 | Metacross Otw, Progreat |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $38.67 | 2025 | Igt Devices Undivided |
| Medtronic Vascular, INC. | $33.71 | 2020 | |
| Pfizer INC. | $27.56 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $23.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.98 | 2020 | |
| Lantheus Medical Imaging, INC. | $19.09 | 2019 | |
| Bridgebio Pharma, INC. | $19.00 | 2025 | Attruby |
| Biotronik INC. | $18.49 | 2021 | |
| Kestra Medical Technology Services, INC. | $14.99 | 2025 | Assure Wcd |
| Teva Pharmaceuticals USA, INC. | $14.49 | 2025 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mazin Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.